Depression in Down Syndrome: Prevalence, Presentation & Tailored Care

Individuals with Down syndrome (trisomy 21) experience depression at comparable or higher rates than the general population (estimated 10–20% vs. 7%), but diagnosis is often missed due to diagnostic overshadowing.

Unique Risk Factors

  • Neurobiology: Altered monoamine systems, early Alzheimer's pathology (APP gene on chr21), smaller hippocampus
  • Psychosocial: Communication barriers, social exclusion, bullying, limited autonomy, grief from losses
  • Medical comorbidities: Hypothyroidism (25–40%), sleep apnea (50–100%), celiac, atlantoaxial instability, chronic pain
  • Life transitions: School exit, aging caregivers, sibling caregiving burden

Atypical Presentation (Diagnostic Overshadowing)

  • Behavioral regression (loss of skills) rather than verbalized sadness
  • Increased agitation, aggression, self-injury
  • Sleep/appetite disruption more prominent than mood report
  • Somatic complaints (GI, pain) without clear source
  • Functional decline in ADLs

Assessment Adaptations

  • Use informant-based tools (e.g., DASH-II, Reiss Screen)
  • Rule out medical causes FIRST (thyroid, apnea, pain, B12/folate, medication side effects)
  • Collateral from caregivers, staff, job coaches
  • Baseline functioning comparison essential

Treatment Principles

  • SSRIs first-line (sertraline, escitalopram) – start low, go slow; monitor activation, GI effects
  • Psychotherapy adaptations: Concrete, visual, repetitive, caregiver-involved (CBT, behavioral activation)
  • Treat medical comorbidities – often resolves "depression"
  • Environmental enrichment: Meaningful activity, social inclusion, choice-making
  • Family/caregiver support – respite, psychoeducation

Key Message

Depression in Down syndrome is real, treatable, and frequently unrecognized. Assume competence, investigate thoroughly, treat holistically.

Depression - Related Articles